Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Celiteq is a Swedish biotechnology company that develops and manufactures advanced microcarriers for the large-scale expansion of adherent cells. The company's proprietary technology provides high-performance surfaces optimized for cell attachment, proliferation, and harvesting in 3D bioreactor environments. These solutions are specifically designed to support the production of vaccines, viral vectors, and cell-based therapies. By enabling the transition from labor-intensive 2D cultures to scalable 3D systems, Celiteq helps biopharmaceutical manufacturers increase yields and reduce production costs. The company's products are utilized across various cell types, including mesenchymal stem cells (MSCs) and established cell lines like Vero and HEK293.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Celiteq.